Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Removed the disease label 'Lung cancer' and the related topics section 'MedlinePlus Genetics' from the page.
    Difference
    0.1%
    Check dated 2026-04-09T21:30:41.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Lung cancer and MedlinePlus Genetics related topics were added.
    Difference
    0.1%
    Check dated 2026-04-02T15:28:26.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:10:51.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows a new revision tag, v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:39:01.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Deleted the topic tags 'Lung cancer' and 'MedlinePlus Genetics' from the study's related topics.
    Difference
    0.1%
    Check dated 2026-02-25T18:36:56.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added Lung cancer and related topics, including MedlinePlus Genetics, and updated the page revision to v3.4.2. Removed the government funding lapse notice and the previous revision v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:57:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.